Example collocations logo

Vaccines in sentence

693 examples of Vaccines in a sentence

A new study, published in February in the journal Health Affairs, suggests that there is another option: in many cases, the medical bills can be preempted by prevention, through the widespread and affordable use of vaccines.
We already know that vaccines are one of the most cost-effective ways to prevent disease and death, and the new study provides additional supporting evidence.
By modeling the health and economic impact of childhood vaccines for ten diseases in 41 of the poorest countries, the researchers estimate that from 2016 to 2030, these vaccines will prevent 36 million deaths.
This study builds on a growing body of evidence that vaccines not only save lives, but also build economies.
Previous studies have estimated that every dollar invested in vaccines saves $16 in terms of health-care costs, lost wages, and lost productivity due to illness, or $44 if the broader benefits of people living longer, healthier lives are taken into account.
Over the next decade and a half, vaccines will save millions of families from the grinding misery of extreme poverty.
Beyond effective collaboration, success will demand improved surveillance and greater innovation, particularly in diagnostics, drugs and vaccines, insecticides, and vector control.
While a solar panel can provide energy for a light bulb and a charge for a cell phone, it does little to help run stoves to avoid indoor air pollution or fridges to keep vaccines and food fresh, much less power agriculture and industry.
Rounding out my top ten was the creation of the Coalition for Epidemic Preparedness Innovations (CEPI), which was established to develop vaccines for infectious disease threats.
Launched with nearly $600 million in funding from Germany, Japan, Norway, the UK charity Wellcome Trust, and the Bill & Melinda Gates Foundation, CEPI aims to reduce sharply the time it takes to develop and produce vaccines.
When Populism Can KillLONDON – Unfounded skepticism about vaccines in some communities, in developing and developed countries alike, has emerged in recent years as one of the most serious impediments to global progress in public health.
By preventing infections, vaccines also prevent overuse of antibiotics, thereby slowing down the development of drug resistance.
Alongside coordinated action on the ground, increasing openness and collaboration among scientists researching and developing a new generation of medicines and vaccines is paving the way for further progress.
Where We Must VaccinateKARACHI/GANDHIDHAM-GUJARAT – With measles outbreaks currently spreading across Europe and the Midwestern United States, and meningitis infecting US college students, health experts are doing something they never thought they’d have to do in early 2017: reminding people in developed countries that vaccines save lives.
Perhaps vaccines are a victim of their own success: they work so well in protecting people against certain illnesses that many in the West have forgotten how devastating preventable diseases can be.
What they need is access to vaccines.
On average, 90% of children in South Asia now receive vaccines for preventable illnesses such as tetanus, influenza, diphtheria, and pertussis, and the number of infants protected against Hepatitis B has increased by nearly 60% in the last decade.
First, we must resolve systemic weaknesses in the region’s underdeveloped health systems, by improving training for health workers, ensuring proper storage and transportation of vaccines, and developing effective ways to deliver them.
Finally, we must continue to encourage countries in the region to increase vaccine coverage rates, in particular with newer vaccines proven to protect against pneumonia and diarrhea, the two leading infectious killers of children.
But, with help from Gavi, the Vaccine Alliance, more vaccines are being brought to the world’s poorest communities through funding, training, and delivery.
Vaccines are a proven tool for improving children’s health and development.
And many die simply because there are no cures or vaccines, because so little of the world’s valuable research talent and limited resources is devoted to addressing the diseases of the poor.
Vaccines Versus SuperbugsLONDON – The outbreak of the Zika virus, like Ebola before it, has highlighted the risk that infectious diseases can pose to the health of entire countries – and the importance of vaccines to the fight against fast-moving epidemics.
But vaccines also have a crucial role to play in protecting us against a far deadlier and far more predictable threat: drug-resistant infections.
But vaccines offer a unique opportunity.
As a result, we are not moving fast enough to develop the types of vaccines that could be used to prevent antimicrobial resistance.
It is a high-risk endeavor, with the vast majority of potential vaccines failing to reach the market.
Consequently, many vaccines are not commercially viable, even if they would be useful for society.
Nor are there enough candidate vaccines against these pathogens undergoing clinical trials.
There have also been problems developing vaccines to combat tuberculosis or – more worrying still – multidrug-resistant TB.
BackNext